Medical Literacy in TIA (Transient Ischemic Attack) Patients
Launched by HOSPICES CIVILS DE LYON · Jun 26, 2025
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how much people who have had a transient ischemic attack (TIA), often called a "mini-stroke," understand about their condition. A TIA is a warning sign that a person may be at risk for a full stroke, which can cause serious health problems. The study wants to find out what patients know about the symptoms of TIA and stroke, the risk factors that increase the chance of having one, and what actions they should take if symptoms happen again. The researchers believe that even after seeing a doctor in the emergency room, many patients might not fully understand these important details.
The trial is for adults aged 18 and older who have recently been treated for a TIA in the emergency department and are now visiting a neurology clinic at the Pierre Wertheimer neurological hospital. To take part, patients must be able to complete a questionnaire, speak French, and not have had a previous stroke or TIA. Participants will be asked to share what they know about their condition, helping doctors learn how to better educate patients in the future. This study has not started recruiting yet, but it aims to improve how people with TIA recognize symptoms and manage their health to prevent future strokes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria :
- • Adult men and women ≥18 years old
- • Patient referred to neurology day hospital at the Pierre Wertheimer neurological hospital after first care in the emergency department
- • Patient having been informed and having expressed his non-opposition
- • Patient affiliate to a social security scheme
- Exclusion Criteria :
- • Patient unable to complete the questionnaire
- • History of stroke/TIA
- • Patient who do not understand the French language
- • Patient under legal protection, guardianship, curatorship, under judicial protection-
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bron, , France
Patients applied
Trial Officials
Mathis Labeylie, DR
Principal Investigator
Hospices Civils de Lyon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported